Pyruvate dehydrogenase kinases in the nervous system: Their principal functions in neuronal-glial metabolic interaction and neuro-metabolic disorders

Current Neuropharmacology

Volumn 10, Issue 4, 2012, Pages 393-403

  Jha, Mithilesh Kumar ^a   Jeon, Sangmin ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Aerobic glycolysis; Neuro metabolic disorders; Neuronal glial interaction; Oxidative phosphorylation; Pyruvate dehydrogenase complex; Pyruvate dehydrogenase kinase

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 2; PYRUVATE DEHYDROGENASE KINASE 4;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN INJURY; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA CELL; GLIOBLASTOMA; GLYCOLYSIS; HUMAN; METABOLIC DISORDER; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW;

EID: 84874851753     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015912804499528     Document Type: Review

References (141)

1. Dunford, E.C.; Herbst, E.A.; Jeoung, N.H.; Gittings, W.; Inglis, J.G.; Vandenboom, R.; LeBlanc, P.J.; Harris, R.A.; Peters, S.J. PDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: effect of PDH kinase 1 compensation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011, 300(6), R1487-1493.
2. Denton, R.M.; Halestrap, A.P. Regulation of pyruvate metabolism in mammalian tissues. Essays Biochem., 1979, 15, 37-77.
3. Peters, S.J.; St Amand, T.A.; Howlett, R.A.; Heigenhauser, G.J.; Spriet, L.L. Human skeletal muscle pyruvate dehydrogenase kinase activity increases after a low-carbohydrate diet. Am. J. Physiol., 1998, 275(6 Pt 1), E980-986.
4. Smolle, M.; Prior, A.E.; Brown, A.E.; Cooper, A.; Byron, O.; Lindsay, J.G. A new level of architectural complexity in the human pyruvate dehydrogenase complex. J. Biol. Chem., 2006, 281(28), 19772-19780.
5. Sanderson, S.J.; Miller, C.; Lindsay, J.G. Stoichiometry, organisation and catalytic function of protein X of the pyruvate dehydrogenase complex from bovine heart. Eur. J. Biochem., 1996, 236(1), 68-77.
6. Reed, L.J.; Hackert, M.L. Structure-function relationships in dihydrolipoamide acyltransferases. J. Biol. Chem., 1990, 265(16), 8971-8974.
7. Maeng, C.Y.; Yazdi, M.A.; Niu, X.D.; Lee, H.Y.; Reed, L.J. Expression, purification, and characterization of the dihydrolipoamide dehydrogenase-binding protein of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae. Biochemistry, 1994, 33(46), 13801-13807.
8. Harris, R.A.; Bowker-Kinley, M.M.; Wu, P.; Jeng, J.; Popov, K.M. Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. DNA-derived amino acid sequence, expression, and reconstitution of the pyruvate dehydrogenase complex. J. Biol. Chem., 1997, 272(32), 19746-19751.
9. Schurr, A.; Payne, R.S. Lactate, not pyruvate, is neuronal aerobic glycolysis end product: an in vitro electrophysiological study. Neuroscience, 2007, 147(3), 613-619.
10. Harris, R.A.; Bowker-Kinley, M.M.; Huang, B.; Wu, P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv. Enzyme Regul., 2002, 42, 249-259.
11. Harris, R.A.; Huang, B.; Wu, P. Control of pyruvate dehydrogenase kinase gene expression. Adv. Enzyme Regul., 2001, 41, 269-288.
12. Gudi, R.; Bowker-Kinley, M.M.; Kedishvili, N.Y.; Zhao, Y.; Popov, K.M. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J. Biol. Chem., 1995, 270(48), 28989-28994.
13. Machius, M.; Chuang, J.L.; Wynn, R.M.; Tomchick, D.R.; Chuang, D.T. Structure of rat BCKD kinase: nucleotide-induced domain communication in a mitochondrial protein kinase. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(20), 11218-11223.
14. Steussy, C.N.; Popov, K.M.; Bowker-Kinley, M.M.; Sloan, R.B., Jr.; Harris, R.A.; Hamilton, J.A. Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase. J. Biol. Chem., 2001, 276(40), 37443-37450.
15. Rowles, J.; Scherer, S.W.; Xi, T.; Majer, M.; Nickle, D.C.; Rommens, J.M.; Popov, K.M.; Harris, R.A.; Riebow, N.L.; Xia, J.; Tsui, L.C.; Bogardus, C.; Prochazka, M. Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J. Biol. Chem., 1996, 271(37), 22376-22382.
16. Bowker-Kinley, M.; Popov, K.M. Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase superfamily. Biochem. J., 1999, 344 Pt 1, 47-53.
17. Wynn, R.M.; Chuang, J.L.; Cote, C.D.; Chuang, D.T. Tetrameric assembly and conservation in the ATP-binding domain of rat branched-chain alpha-ketoacid dehydrogenase kinase. J. Biol. Chem., 2000, 275(39), 30512-30519.
18. Sugden, M.C.; Holness, M.J. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch. Physiol. Biochem., 2006, 112(3), 139-149.
19. Sugden, M.C.; Holness, M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am. J. Physiol. Endocrinol. Metab., 2003, 284(5), E855-862.
20. Sugden, M.C.; Bulmer, K.; Holness, M.J. Fuel-sensing mechanisms integrating lipid and carbohydrate utilization. Biochem. Soc. Trans, 2001, 29(Pt 2), 272-278.
21. Huang, B.; Wu, P.; Popov, K.M.; Harris, R.A. Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney. Diabetes, 2003, 52(6), 1371-1376.
22. Popov, K.M.; Hawes, J.W.; Harris, R.A. Mitochondrial alphaketoacid dehydrogenase kinases: a new family of protein kinases. Adv. Second Messenger Phosphoprotein Res., 1997, 31, 105-111.
23. Wu, P.; Sato, J.; Zhao, Y.; Jaskiewicz, J.; Popov, K.M.; Harris, R.A. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem. J., 1998, 329 (Pt 1), 197-201.
24. Di, R.M.; Feng, Q.T.; Chang, Z.; Luan, Q.; Zhang, Y.Y.; Huang, J.; Li, X.L.; Yang, Z.Z. PDK1 plays a critical role in regulating cardiac function in mice and human. Chin. Med. J. (Engl)., 2010, 123(17), 2358-2363.
25. Sugden, M.C.; Bulmer, K.; Augustine, D.; Holness, M.J. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion. Diabetes, 2001, 50(12), 2729-2736.
26. Spriet, L.L.; Tunstall, R.J.; Watt, M.J.; Mehan, K.A.; Hargreaves, M.; Cameron-Smith, D. Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting. J. Appl. Physiol., 2004, 96(6), 2082-2087.
27. Bowker-Kinley, M.M.; Davis, W.I.; Wu, P.; Harris, R.A.; Popov, K.M. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem. J., 1998, 329 (Pt 1), 191-196.
28. Wu, P.; Blair, P.V.; Sato, J.; Jaskiewicz, J.; Popov, K.M.; Harris, R.A. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch. Biochem. Biophys., 2000, 381(1), 1-7.
29. Teague, W.M.; Pettit, F.H.; Yeaman, S.J.; Reed, L.J. Function of phosphorylation sites on pyruvate dehydrogenase. Biochem. Biophys. Res. Commun., 1979, 87(1), 244-252.
30. Korotchkina, L.G.; Patel, M.S. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase. J. Biol. Chem., 2001, 276(40), 37223-37229.
31. Popov, K.M.; Kedishvili, N.Y.; Zhao, Y.; Gudi, R.; Harris, R.A. Molecular cloning of the p45 subunit of pyruvate dehydrogenase kinase. J. Biol. Chem., 1994, 269(47), 29720-29724.
32. Wynn, R.M.; Kato, M.; Chuang, J.L.; Tso, S.C.; Li, J.; Chuang, D.T. Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity. J. Biol. Chem., 2008, 283(37), 25305-25315.
33. Popov, K.M.; Kedishvili, N.Y.; Zhao, Y.; Shimomura, Y.; Crabb, D.W.; Harris, R.A. Primary structure of pyruvate dehydrogenase kinase establishes a new family of eukaryotic protein kinases. J. Biol. Chem., 1993, 268(35), 26602-26606.
34. LeBlanc, P.J.; Peters, S.J.; Tunstall, R.J.; Cameron-Smith, D.; Heigenhauser, G.J. Effects of aerobic training on pyruvate dehydrogenase and pyruvate dehydrogenase kinase in human skeletal muscle. J. Physiol., 2004, 557(Pt 2), 559-570.
35. Huang, B.; Gudi, R.; Wu, P.; Harris, R.A.; Hamilton, J.; Popov, K.M. Isoenzymes of pyruvate dehydrogenase phosphatase. DNAderived amino acid sequences, expression, and regulation. J. Biol. Chem., 1998, 273(28), 17680-17688.
36. Xing, G.; Ren, M.; O'Neill, J.T.; Verma, A.; Watson, W.D. Controlled cortical impact injury and craniotomy result in divergent alterations of pyruvate metabolizing enzymes in rat brain. Exp. Neurol., 2012, 234(1), 31-38.
37. Holness, M.J.; Sugden, M.C. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem. Soc. Trans, 2003, 31(Pt 6), 1143-1151.
38. Tokmakov, A.A. Comparative homology modeling of pyruvate dehydrogenase kinase isozymes from Xenopus tropicalis reveals structural basis for their subfunctionalization. J. Mol. Model, 2011.
39. Laurencikiene, J.; Stenson, B.M.; Arvidsson Nordstrom, E.; Agustsson, T.; Langin, D.; Isaksson, B.; Permert, J.; Ryden, M.; Arner, P. Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res., 2008, 68(22), 9247-9254.
40. Randle, P.J. Fuel selection in animals. Biochem. Soc. Trans, 1986, 14(5), 799-806.
41. Patel, M.S.; Roche, T.E. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J., 1990, 4(14), 3224-3233.
42. Sugden, M.C.; Orfali, K.A.; Fryer, L.G.; Holness, M.J.; Priestman, D.A. Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase: regulation by insulin, cyclic AMP and pyruvate. J. Mol. Cell Cardiol., 1997, 29(7), 1867-1875.
43. Randle, P.J. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev., 1998, 14(4), 263-283.
44. Patel, M.S.; Korotchkina, L.G. Regulation of the pyruvate dehydrogenase complex. Biochem. Soc. Trans, 2006, 34(Pt 2), 217-222.
45. Priestman, D.A.; Mistry, S.C.; Halsall, A.; Randle, P.J. Role of protein synthesis and of fatty acid metabolism in the longer-term regulation of pyruvate dehydrogenase kinase. Biochem. J., 1994, 300 (Pt 3), 659-664.
46. Denton, R.M.; McCormack, J.G.; Rutter, G.A.; Burnett, P.; Edgell, N.J.; Moule, S.K.; Diggle, T.A. The hormonal regulation of pyruvate dehydrogenase complex. Adv. Enzyme Regul., 1996, 36, 183-198.
47. Roche, T.E.; Baker, J.C.; Yan, X.; Hiromasa, Y.; Gong, X.; Peng, T.; Dong, J.; Turkan, A.; Kasten, S.A. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid Res. Mol. Biol., 2001, 70, 33-75.
48. Wang, Z.; Iwasaki, Y.; Zhao, L.F.; Nishiyama, M.; Taguchi, T.; Tsugita, M.; Kambayashi, M.; Hashimoto, K.; Terada, Y. Hormonal regulation of glycolytic enzyme gene and pyruvate dehydrogenase kinase/phosphatase gene transcription. Endocr. J., 2009, 56(8), 1019-1030.
49. Zhou, Q.; Lam, P.Y.; Han, D.; Cadenas, E. Activation of c-Jun-Nterminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett., 2009, 583(7), 1132-1140.
50. Holness, M.J.; Smith, N.D.; Bulmer, K.; Hopkins, T.; Gibbons, G.F.; Sugden, M.C. Evaluation of the role of peroxisomeproliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Biochem. J., 2002, 364(Pt 3), 687-694.
51. Huang, B.; Wu, P.; Bowker-Kinley, M.M.; Harris, R.A. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes, 2002, 51(2), 276-283.
52. Yao, J.; Irwin, R.W.; Zhao, L.; Nilsen, J.; Hamilton, R.T.; Brinton, R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad Sci. U. S. A., 2009, 106(34), 14670-14675.
53. Pelicano, H.; Martin, D.S.; Xu, R.H.; Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene, 2006, 25(34), 4633-4646.
54. Stacpoole, P.W. The pharmacology of dichloroacetate. Metabolism, 1989, 38(11), 1124-1144.
55. Bonnet, S.; Archer, S.L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C.T.; Lopaschuk, G.D.; Puttagunta, L.; Harry, G.; Hashimoto, K.; Porter, C.J.; Andrade, M.A.; Thebaud, B.; Michelakis, E.D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 2007, 11(1), 37-51.
56. Pan, J.G.; Mak, T.W. Metabolic targeting as an anticancer strategy: dawn of a new era? Sci. STKE, 2007, 2007(381), pe14.
57. Balmaceda-Aguilera, C.; Cortes-Campos, C.; Cifuentes, M.; Peruzzo, B.; Mack, L.; Tapia, J.C.; Oyarce, K.; Garcia, M.A.; Nualart, F. Glucose Transporter 1 and Monocarboxylate Transporters 1, 2, and 4 Localization within the Glial Cells of Shark Blood-Brain-Barriers. PLoS One, 2012, 7(2), e32409.
58. Matsumoto, K.; Akazawa, S.; Ishibashi, M.; Trocino, R.A.; Matsuo, H.; Yamasaki, H.; Yamaguchi, Y.; Nagamatsu, S.; Nagataki, S. Abundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. Biochem. Biophys. Res. Commun., 1995, 209(1), 95-102.
59. Silver, I.A.; Deas, J.; Erecinska, M. Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience, 1997, 78(2), 589-601.
60. Yu, A.C.; Drejer, J.; Hertz, L.; Schousboe, A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem., 1983, 41(5), 1484-1487.
61. Martinez-Hernandez, A.; Bell, K.P.; Norenberg, M.D. Glutamine synthetase: glial localization in brain. Science, 1977, 195(4284), 1356-1358.
62. Halim, N.D.; McFate, T.; Mohyeldin, A.; Okagaki, P.; Korotchkina, L.G.; Patel, M.S.; Jeoung, N.H.; Harris, R.A.; Schell, M.J.; Verma, A. Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia, 2010, 58(10), 1168-1176.
63. Magistretti, P.J.; Pellerin, L.; Rothman, D.L.; Shulman, R.G. Energy on demand. Science, 1999, 283(5401), 496-497.
64. Magistretti, P.J. Neuron-glia metabolic coupling and plasticity. J. Exper. Biol., 2006, 209(Pt 12), 2304-2311.
65. Takano, T.; Tian, G.F.; Peng, W.; Lou, N.; Libionka, W.; Han, X.; Nedergaard, M. Astrocyte-mediated control of cerebral blood flow. Nat. Neuroscience, 2006, 9(2), 260-267.
66. Brightman, M.W.; Reese, T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol., 1969, 40(3), 648-677.
67. Barros, L.F.; Bittner, C.X.; Loaiza, A.; Porras, O.H. A quantitative overview of glucose dynamics in the gliovascular unit. Glia, 2007, 55(12), 1222-1237.
68. Simpson, I.A.; Carruthers, A.; Vannucci, S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cerebral. Blood Flow Metabol., 2007, 27(11), 1766-1791.
69. Dienel, G.A.; Nelson, T.; Cruz, N.F.; Jay, T.; Crane, A.M.; Sokoloff, L. Over-estimation of glucose-6-phosphatase activity in brain in vivo. Apparent difference in rates of [2-3H]glucose and [U-14C]glucose utilization is due to contamination of precursor pool with 14C-labeled products and incomplete recovery of 14C-labeled metabolites. J. Biol. Chem., 1988, 263(36), 19697-19708.
70. Dringen, R.; Gebhardt, R.; Hamprecht, B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res., 1993, 623(2), 208-214.
71. Pellerin, L.; Magistretti, P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Pro. Natl. Acad. Sci. U. S. A., 1994, 91(22), 10625-10629.
72. Mangia, S.; Giove, F.; Tkac, I.; Logothetis, N.K.; Henry, P.G.; Olman, C.A.; Maraviglia, B.; Di Salle, F.; Ugurbil, K. Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J. Cerebral Blood Flow Metabol., 2009, 29(3), 441-463.
73. Hertz, L.; Dienel, G.A. Energy metabolism in the brain. Int. Rev. Neurobiol., 2002, 51, 1-102.
74. Gjedde, A.; Marrett, S.; Vafaee, M. Oxidative and nonoxidative metabolism of excited neurons and astrocytes. J. Cerebral Blood Flow Metabol., 2002, 22(1), 1-14.
75. Gladden, L.B. Lactate metabolism: a new paradigm for the third millennium. J. Physiol., 2004, 558(Pt 1), 5-30.
76. Occhipinti, R.; Somersalo, E.; Calvetti, D. Astrocytes as the glucose shunt for glutamatergic neurons at high activity: an in silico study. J. Neurophysiol., 2009, 101(5), 2528-2538.
77. Chih, C.P.; Lipton, P.; Roberts, E.L., Jr. Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci., 2001, 24(10), 573-578.
78. Bonvento, G.; Herard, A.S.; Voutsinos-Porche, B. The astrocyte--neuron lactate shuttle: a debated but still valuable hypothesis for brain imaging. J. Cerebral Blood Flow Metabol., 2005, 25(10), 1394-1399.
79. Leybaert, L. Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J. Cerebral Blood Flow Metabol., 2005, 25(1), 2-16.
80. Dienel, G.A.; Cruz, N.F. Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought? Neurochem. Internat., 2004, 45(2-3), 321-351.
81. Pellerin, L.; Bouzier-Sore, A.K.; Aubert, A.; Serres, S.; Merle, M.; Costalat, R.; Magistretti, P.J. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia, 2007, 55(12), 1251-1262.
82. Nehlig, A.; Coles, J.A. Cellular pathways of energy metabolism in the brain: is glucose used by neurons or astrocytes? Glia, 2007, 55(12), 1238-1250.
83. Gandhi, G.K.; Cruz, N.F.; Ball, K.K.; Dienel, G.A. Astrocytes are poised for lactate trafficking and release from activated brain and for supply of glucose to neurons. J. Neurochem., 2009, 111(2), 522-536.
84. Mangia, S.; Simpson, I.A.; Vannucci, S.J.; Carruthers, A. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J. Neurochem., 2009, 109 Suppl 1, 55-62.
85. Aubert, A.; Costalat, R.; Magistretti, P.J.; Pellerin, L. Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(45), 16448-16453.
86. Hyder, F.; Patel, A.B.; Gjedde, A.; Rothman, D.L.; Behar, K.L.; Shulman, R.G. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J. Cerebral Blood Flow Metabol., 2006, 26(7), 865-877.
87. Aubert, A.; Costalat, R. Compartmentalization of brain energy metabolism between glia and neurons: insights from mathematical modeling. Glia, 2007, 55(12), 1272-1279.
88. Mangia, S.; DiNuzzo, M.; Giove, F.; Carruthers, A.; Simpson, I.A.; Vannucci, S.J. Response to 'comment on recent modeling studies of astrocyte-neuron metabolic interactions': much ado about nothing. J. Cerebral Blood Flow Metabol., 2011, 31(6), 1346-1353.
89. Genc, S.; Kurnaz, I.A.; Ozilgen, M. Astrocyte-neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions--in silico study supported by in vitro expression data. BMC Syst. Biol., 2011, 5, 162.
90. Smallbone, K.; Simeonidis, E.; Swainston, N.; Mendes, P. Towards a genome-scale kinetic model of cellular metabolism. BMC Syst. Biol., 2010, 4, 6.
91. Hauptmann, S.; Scherping, I.; Drose, S.; Brandt, U.; Schulz, K.L.; Jendrach, M.; Leuner, K.; Eckert, A.; Muller, W.E. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging, 2009, 30(10), 1574-1586.
92. Nicholson, R.M.; Kusne, Y.; Nowak, L.A.; LaFerla, F.M.; Reiman, E.M.; Valla, J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res., 2010, 1347, 179-185.
93. Gibson, G.E.; Shi, Q. A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. J. Alzheimers Dis., 2010, 20 Suppl 2, S591-607.
94. Mosconi, L.; Mistur, R.; Switalski, R.; Brys, M.; Glodzik, L.; Rich, K.; Pirraglia, E.; Tsui, W.; De Santi, S.; de Leon, M.J. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology, 2009, 72(6), 513-520.
95. Mosconi, L.; Mistur, R.; Switalski, R.; Tsui, W.H.; Glodzik, L.; Li, Y.; Pirraglia, E.; De Santi, S.; Reisberg, B.; Wisniewski, T.; de Leon, M.J. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(5), 811-822.
96. Reiman, E.M.; Chen, K.; Alexander, G.E.; Caselli, R.J.; Bandy, D.; Osborne, D.; Saunders, A.M.; Hardy, J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad Sci. U. S. A., 2004, 101(1), 284-289.
97. Mosconi, L.; De Santi, S.; Li, J.; Tsui, W.H.; Li, Y.; Boppana, M.; Laska, E.; Rusinek, H.; de Leon, M.J. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging, 2008, 29(5), 676-692.
98. Manczak, M.; Anekonda, T.S.; Henson, E.; Park, B.S.; Quinn, J.; Reddy, P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet, 2006, 15(9), 1437-1449.
99. Devi, L.; Prabhu, B.M.; Galati, D.F.; Avadhani, N.G.; Anandatheerthavarada, H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci., 2006, 26(35), 9057-9068.
100. Caspersen, C.; Wang, N.; Yao, J.; Sosunov, A.; Chen, X.; Lustbader, J.W.; Xu, H.W.; Stern, D.; McKhann, G.; Yan, S.D. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J., 2005, 19(14), 2040-2041.
101. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C.S.; Petersen, R.B.; Smith, M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol., 2001, 60(8), 759-767.
102. DeKosky, S.T.; Scheff, S.W.; Styren, S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration, 1996, 5(4), 417-421.
103. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science, 2002, 298(5594), 789-791.
104. Beal, M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol., 2005, 58(4), 495-505.
105. Reddy, P.H.; Beal, M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med., 2008, 14(2), 45-53.
106. Park, L.C.; Zhang, H.; Sheu, K.F.; Calingasan, N.Y.; Kristal, B.S.; Lindsay, J.G.; Gibson, G.E. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem., 1999, 72(5), 1948-1958.
107. Starkov, A.A.; Fiskum, G.; Chinopoulos, C.; Lorenzo, B.J.; Browne, S.E.; Patel, M.S.; Beal, M.F. Mitochondrial alphaketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci., 2004, 24(36), 7779-7788.
108. Blass, J.P. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann. N. Y. Acad Sci., 2000, 924, 170-183.
109. Pratico, D.; Yao, Y.; Rokach, J.; Mayo, M.; Silverberg, G.G.; McGuire, D. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients. J. Alzheimers Dis., 2004, 6(4), 385-389; discussion 443-389.
110. Pocernich, C.B.; Butterfield, D.A. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res., 2003, 5(7), 515-520.
111. Sun, L.; Luo, C.; Long, J.; Wei, D.; Liu, J. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion, 2006, 6(3), 136-142.
112. Lovell, M.A.; Xie, C.; Markesbery, W.R. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radical Biol. Med., 2000, 29(8), 714-720.
113. Nakai, N.; Obayashi, M.; Nagasaki, M.; Sato, Y.; Fujitsuka, N.; Yoshimura, A.; Miyazaki, Y.; Sugiyama, S.; Shimomura, Y. The abundance of mRNAs for pyruvate dehydrogenase kinase isoenzymes in brain regions of young and aged rats. Life Sci., 2000, 68(5), 497-503.
114. Navarro, A.; Sanchez Del Pino, M.J.; Gomez, C.; Peralta, J.L.; Boveris, A. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2002, 282(4), R985-992.
115. Katoh-Semba, R.; Keino, H.; Kashiwamata, S. A possible contribution by glial cells to neuronal energy production: enzymehistochemical studies in the developing rat cerebellum. Cell Tissue Res., 1988, 252(1), 133-139.
116. Wang, J.; Bai, L.; Li, J.; Sun, C.; Zhao, J.; Cui, C.; Han, K.; Liu, Y.; Zhuo, X.; Wang, T.; Liu, P.; Fan, F.; Guan, Y.; Ma, A. Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart. Science in China. Series C, Life Sci., 2009, 52(11), 1003-1010.
117. Stacpoole, P.W. The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases. Aging Cell, 2012.
118. Michelakis, E.D.; Sutendra, G.; Dromparis, P.; Webster, L.; Haromy, A.; Niven, E.; Maguire, C.; Gammer, T.L.; Mackey, J.R.; Fulton, D.; Abdulkarim, B.; McMurtry, M.S.; Petruk, K.C. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med., 2010, 2(31), 31ra34.
119. Ohgaki, H.; Kleihues, P. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol., 2007, 170(5), 1445-1453.
120. Lu, H.; Forbes, R.A.; Verma, A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem., 2002, 277(26), 23111-23115.
121. Michelakis, E.D.; Webster, L.; Mackey, J.R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br. J. Cancer, 2008, 99(7), 989-994.
122. Dang, C.V. The interplay between MYC and HIF in the Warburg effect. Ernst Schering Found Symp Proc., 2007, (4), 35-53.
123. Kim, J.W.; Tchernyshyov, I.; Semenza, G.L.; Dang, C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 2006, 3(3), 177-185.
124. Kim, J.W.; Gao, P.; Liu, Y.C.; Semenza, G.L.; Dang, C.V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell Biol., 2007, 27(21), 7381-7393.
125. Papandreou, I.; Cairns, R.A.; Fontana, L.; Lim, A.L.; Denko, N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab., 2006, 3(3), 187-197.
126. Lu, H.; Dalgard, C.L.; Mohyeldin, A.; McFate, T.; Tait, A.S.; Verma, A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem., 2005, 280(51), 41928-41939.
127. McFate, T.; Mohyeldin, A.; Lu, H.; Thakar, J.; Henriques, J.; Halim, N.D.; Wu, H.; Schell, M.J.; Tsang, T.M.; Teahan, O.; Zhou, S.; Califano, J.A.; Jeoung, N.H.; Harris, R.A.; Verma, A. Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J. Biol. Chem., 2008, 283(33), 22700-22708.
128. Fiskum, G.; Rosenthal, R.E.; Vereczki, V.; Martin, E.; Hoffman, G.E.; Chinopoulos, C.; Kowaltowski, A. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J. Bioenerg. Biomembr., 2004, 36(4), 347-352.
129. Verweij, B.H.; Muizelaar, J.P.; Vinas, F.C.; Peterson, P.L.; Xiong, Y.; Lee, C.P. Impaired cerebral mitochondrial function after traumatic brain injury in humans. J. Neurosurg., 2000, 93(5), 815-820.
130. Xiong, Y.; Gu, Q.; Peterson, P.L.; Muizelaar, J.P.; Lee, C.P. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J. Neurotrauma, 1997, 14(1), 23-34.
131. Verweij, B.H.; Muizelaar, J.P.; Vinas, F.C.; Peterson, P.L.; Xiong, Y.; Lee, C.P. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111). Neurol. Res., 1997, 19(3), 334-339.
132. Vespa, P.; Bergsneider, M.; Hattori, N.; Wu, H.M.; Huang, S.C.; Martin, N.A.; Glenn, T.C.; McArthur, D.L.; Hovda, D.A. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J. Cereb. Blood Flow Metab., 2005, 25(6), 763-774.
133. Prins, M.L.; Lee, S.M.; Fujima, L.S.; Hovda, D.A. Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J. Neurochem., 2004, 90(3), 666-672.
134. Lifshitz, J.; Friberg, H.; Neumar, R.W.; Raghupathi, R.; Welsh, F.A.; Janmey, P.; Saatman, K.E.; Wieloch, T.; Grady, M.S.; McIntosh, T.K. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J. Cereb. Blood Flow Metab., 2003, 23(2), 219-231.
135. Hillered, L.; Enblad, P. Nonischemic energy metabolic crisis in acute brain injury. Crit. Care Med., 2008, 36(10), 2952-2953.
136. Hattori, N.; Huang, S.C.; Wu, H.M.; Yeh, E.; Glenn, T.C.; Vespa, P.M.; McArthur, D.; Phelps, M.E.; Hovda, D.A.; Bergsneider, M. Correlation of regional metabolic rates of glucose with glasgow coma scale after traumatic brain injury. J. Nucl. Med., 2003, 44(11), 1709-1716.
137. Yoshino, A.; Hovda, D.A.; Kawamata, T.; Katayama, Y.; Becker, D.P. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper-and subsequent hypometabolic state. Brain Res., 1991, 561(1), 106-119.
138. Roche, T.E.; Hiromasa, Y. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol. Life Sci., 2007, 64(7-8), 830-849.
139. Xing, G.; Ren, M.; Watson, W.D.; O'Neill, J.T.; Verma, A. Traumatic brain injury-induced expression and phosphorylation of pyruvate dehydrogenase: a mechanism of dysregulated glucose metabolism. Neurosci. Lett., 2009, 454(1), 38-42.
140. Opii, W.O.; Nukala, V.N.; Sultana, R.; Pandya, J.D.; Day, K.M.; Merchant, M.L.; Klein, J.B.; Sullivan, P.G.; Butterfield, D.A. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J. Neurotrauma, 2007, 24(5), 772-789.
141. Robertson, C.L.; Saraswati, M.; Fiskum, G. Mitochondrial dysfunction early after traumatic brain injury in immature rats. J. Neurochem., 2007, 101(5), 1248-1257.